Clinical Trial

TTVR Early Feasibility Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-08
notable Primary completion pushed: 2026-07-30 -> 2026-09-10 2026-08-08
Trial Details
NCT Number NCT04433065
Lead Sponsor Medtronic Cardiovascular
Conditions Tricuspid Regurgitation
Enrollment 150 participants
Start Date 2020-10-20
Primary Completion 2026-09-10 (estimated)
Study Completion 2031-08-26 (estimated)
Updated on ClinicalTrials.gov 2026-08-07